65,437 trials
Hepatitis B, Chronic
Primary: Percentage of Participants With Hepatitis B Envelope Antigen (HBeAg) Seroconversion. — 9.7; 14.6; 19.8; 31.6 Percentage of participants
Bone Pain in Stage I - III Breast Cancer
Primary: Percentage of Participants With Bone Pain (All Grades) in Cycle 1 — 46.6; 40.3; 42.5 percentage of participants
Back Pain
Primary: Change in Average Daily Pain Visual Analog Scale (VAS) Score Between Screening and Follow up. — -2.4; -0.56 units on a scale
HIV Infections · Heart Disease
Primary: Bone Mineral Density (BMD) — -0.03; -0.53 percentage of change
Depressive Symptoms
Primary: Change in BDI-II Depressive Symptom Scores — -13.9; -13.3 scores on BDI-II scale — p=0.21
Weight Loss
Primary: Mean Change in Body Weight From Baseline to Week 12 — 3.53; 0.14 kilogram (kg)
Sleep Disorders
Primary: Dim Light Melatonin Onset (Hours) — 1.93; 0.80 hours
HIV-associated Enteropathy
Primary: Frequency of Daily Unformed Bowel Movements — -2.46; -2.16; -2.20 abnormal or unformed stools
HIV-1 Infection · HIV Infections
Primary: Safety of the DC Vaccine (as Measured by Frequency of Adverse Events) — 0; 0 participants
Rheumatoid Arthritis
Primary: Percentage of Patients Who Present Adverse Events, Intolerance or Lack of Efficacy to Synthetic DMARDs That Causes a Change in Treatment Prescription When Used in…
Fibromyalgia
Primary: Mean Change From Baseline of Fibromyalgia Impact Questionnaire Score — -27.8; -9.4 units on a scale
Acute Stress Ulcer and Acute Gastric Mucosal Lesions
Primary: Number of Participants Reporting One or More Adverse Drug Reactions — 0 participants
Intestinal Diseases
Primary: PID From Pre-dose Baseline at 20 Minutes After First Injection. — -4.09; -3.66 Units on a scale — p=<0.0001
Chronic Migraine
Primary: Subject Global Impression of Change — 4.43; 5.67; 1.67; 4.76 units on a scale
Strabismus · Delirium on Emergence · Pediatric Disorders
Primary: Percentage of Patients Experiencing Pediatric Emergence Delirium in Strabismus Surgery — 50; 48 percentage of participants